Elite Diagnostic Limited (JMSE:ELITE)
Jamaica · Delayed Price · Currency is JMD 1.380
+0.010 (0.73%)
At close: May 22, 2026
Elite Diagnostic Income Statement
Financials in millions JMD. Fiscal year is July - June.
Millions JMD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 875.78 | 853.82 | 821.28 | 755.33 | 624.22 | 506.91 | |
Revenue Growth (YoY) | 0.32% | 3.96% | 8.73% | 21.00% | 23.14% | 15.26% |
Cost of Revenue | 258.48 | 269.69 | 278.13 | 277.27 | 223.58 | 200.5 |
Gross Profit | 617.3 | 584.14 | 543.16 | 478.06 | 400.64 | 306.4 |
Selling, General & Admin | 346.56 | 342.65 | 311.39 | 276.9 | 210.66 | 174.77 |
Operating Expenses | 523.34 | 512.76 | 446.61 | 413.35 | 318.19 | 276.83 |
Operating Income | 93.96 | 71.38 | 96.54 | 64.71 | 82.45 | 29.58 |
Interest Expense | -34.02 | -28.24 | -48.64 | -32.67 | -27.33 | -21.02 |
Interest & Investment Income | 0.13 | 0.13 | 0.09 | 0.1 | 0.01 | 0.09 |
Currency Exchange Gain (Loss) | 2.11 | 2.62 | -3.32 | -4.56 | -6.47 | -6.72 |
Other Non Operating Income (Expenses) | -9.95 | -10.9 | -14.15 | -14.2 | - | - |
EBT Excluding Unusual Items | 52.23 | 34.99 | 30.53 | 13.39 | 48.66 | 1.93 |
Asset Writedown | 1.93 | 1.93 | -1.18 | - | - | - |
Pretax Income | 54.16 | 36.92 | 29.35 | 13.39 | 48.66 | 1.93 |
Income Tax Expense | 5.29 | 4.9 | 3.19 | 0.04 | - | - |
Net Income | 48.88 | 32.02 | 26.16 | 13.35 | 48.66 | 1.93 |
Net Income to Common | 48.88 | 32.02 | 26.16 | 13.35 | 48.66 | 1.93 |
Net Income Growth | 33.10% | 22.44% | 95.90% | -72.56% | 2422.31% | -77.44% |
Shares Outstanding (Basic) | 302 | 353 | 353 | 353 | 353 | 353 |
Shares Outstanding (Diluted) | 302 | 353 | 353 | 353 | 353 | 353 |
Shares Change (YoY) | -27.09% | - | - | - | - | - |
EPS (Basic) | 0.16 | 0.09 | 0.07 | 0.04 | 0.14 | 0.01 |
EPS (Diluted) | 0.16 | 0.09 | 0.07 | 0.04 | 0.14 | 0.01 |
EPS Growth | 82.56% | 22.44% | 95.91% | -72.56% | 2422.72% | -77.45% |
Free Cash Flow | 74.41 | 167.95 | 92.29 | -25.87 | -127.87 | 38.8 |
Free Cash Flow Per Share | 0.25 | 0.47 | 0.26 | -0.07 | -0.36 | 0.11 |
Dividend Per Share | 0.010 | 0.010 | - | - | 0.020 | 0.090 |
Dividend Growth | - | - | - | - | -77.78% | - |
Gross Margin | 70.48% | 68.41% | 66.14% | 63.29% | 64.18% | 60.45% |
Operating Margin | 10.73% | 8.36% | 11.76% | 8.57% | 13.21% | 5.83% |
Profit Margin | 5.58% | 3.75% | 3.19% | 1.77% | 7.80% | 0.38% |
Free Cash Flow Margin | 8.50% | 19.67% | 11.24% | -3.43% | -20.48% | 7.65% |
EBITDA | 235.72 | 206.47 | 199.83 | 173.05 | 177.25 | 116.11 |
EBITDA Margin | 26.92% | 24.18% | 24.33% | 22.91% | 28.40% | 22.91% |
D&A For EBITDA | 141.77 | 135.1 | 103.29 | 108.33 | 94.8 | 86.53 |
EBIT | 93.96 | 71.38 | 96.54 | 64.71 | 82.45 | 29.58 |
EBIT Margin | 10.73% | 8.36% | 11.76% | 8.57% | 13.21% | 5.83% |
Effective Tax Rate | 9.76% | 13.27% | 10.88% | 0.26% | - | - |
Advertising Expenses | - | 3.42 | 5.23 | 9.61 | 5.9 | 4.06 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.